Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?

The increasing understanding of the molecular biology and the etiopathogenetic mechanisms of asthma helps in identification of numerous phenotypes and endotypes, particularly for severe refractory asthma. For a decade, the only available biologic therapy that met the unmet needs of a specific group...

Descripción completa

Detalles Bibliográficos
Autores principales: Menzella, Francesco, Galeone, Carla, Bertolini, Francesca, Castagnetti, Claudia, Facciolongo, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587160/
https://www.ncbi.nlm.nih.gov/pubmed/28919788
http://dx.doi.org/10.2147/JAA.S144100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587160/
https://www.ncbi.nlm.nih.gov/pubmed/28919788
http://dx.doi.org/10.2147/JAA.S144100

Ejemplares similares